OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Making Sense of a Complex Disease: A Practical Approach to Managing Neuroendocrine Tumors
Janie Y. Zhang, Pamela L. Kunz
JCO Oncology Practice (2021) Vol. 18, Iss. 4, pp. 258-264
Open Access | Times Cited: 28
Janie Y. Zhang, Pamela L. Kunz
JCO Oncology Practice (2021) Vol. 18, Iss. 4, pp. 258-264
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Current and emerging therapies for neuroendocrine prostate cancer
Busola R. Alabi, Shiqin Liu, Tanya Stoyanova
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108255-108255
Closed Access | Times Cited: 42
Busola R. Alabi, Shiqin Liu, Tanya Stoyanova
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108255-108255
Closed Access | Times Cited: 42
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE
Luca Urso, Alberto Nieri, Licia Uccelli, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1110-1110
Open Access | Times Cited: 27
Luca Urso, Alberto Nieri, Licia Uccelli, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1110-1110
Open Access | Times Cited: 27
Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome
Rosaria Maddalena Ruggeri, Elio Benevento, Federica de Cicco, et al.
Endocrine (2023) Vol. 82, Iss. 3, pp. 480-490
Closed Access | Times Cited: 15
Rosaria Maddalena Ruggeri, Elio Benevento, Federica de Cicco, et al.
Endocrine (2023) Vol. 82, Iss. 3, pp. 480-490
Closed Access | Times Cited: 15
Update in the management of gastroenteropancreatic neuroendocrine tumors
Andrew J. H. Sedlack, Diana Grace Varghese, Amirkia Naimian, et al.
Cancer (2024) Vol. 130, Iss. 18, pp. 3090-3105
Closed Access | Times Cited: 5
Andrew J. H. Sedlack, Diana Grace Varghese, Amirkia Naimian, et al.
Cancer (2024) Vol. 130, Iss. 18, pp. 3090-3105
Closed Access | Times Cited: 5
An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects
Erika Stefàno, Federica De Castro, Antonella Ciccarese, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8568-8568
Open Access | Times Cited: 5
Erika Stefàno, Federica De Castro, Antonella Ciccarese, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8568-8568
Open Access | Times Cited: 5
Ectopic GHRH production: revisiting a rare cause of acromegaly
Matheo Augusto Morandi Stumpf, Nathalie Oliveira de Santana, Márcio Carlos Machado, et al.
Reviews in Endocrine and Metabolic Disorders (2025)
Closed Access
Matheo Augusto Morandi Stumpf, Nathalie Oliveira de Santana, Márcio Carlos Machado, et al.
Reviews in Endocrine and Metabolic Disorders (2025)
Closed Access
Neuroendocrine Neoplasms: A Primer on Imaging and Nonsurgical Therapies
Bardia Nadim, Alexander Boyko, Michael P. Kavanaugh, et al.
(2025) Vol. 1, Iss. 1
Closed Access
Bardia Nadim, Alexander Boyko, Michael P. Kavanaugh, et al.
(2025) Vol. 1, Iss. 1
Closed Access
Small-Bowel Neuroendocrine Tumors
Norman Galbraith, Claire Sokas
Diseases of the Colon & Rectum (2024)
Closed Access | Times Cited: 3
Norman Galbraith, Claire Sokas
Diseases of the Colon & Rectum (2024)
Closed Access | Times Cited: 3
Current perspectives on neuroendocrine tumors
Sunil Kumar Verma, R. P. Khare, Devendra Singh
hLife (2024) Vol. 2, Iss. 11, pp. 563-575
Open Access | Times Cited: 3
Sunil Kumar Verma, R. P. Khare, Devendra Singh
hLife (2024) Vol. 2, Iss. 11, pp. 563-575
Open Access | Times Cited: 3
An update on the safety of lanreotide autogel for the treatment of patients with neuroendocrine tumors
Aayushi Sood, Malak Munir, Omar Syed, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 8, pp. 949-957
Closed Access | Times Cited: 2
Aayushi Sood, Malak Munir, Omar Syed, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 8, pp. 949-957
Closed Access | Times Cited: 2
Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival
Ilektra Antonia Mavroeidi, Anna Romanowicz, T. Haake, et al.
Theranostics (2024) Vol. 14, Iss. 14, pp. 5400-5412
Open Access | Times Cited: 2
Ilektra Antonia Mavroeidi, Anna Romanowicz, T. Haake, et al.
Theranostics (2024) Vol. 14, Iss. 14, pp. 5400-5412
Open Access | Times Cited: 2
Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
Krzysztof Kaliszewski, Maksymilian Ludwig, Maria Greniuk, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 2028-2028
Open Access | Times Cited: 10
Krzysztof Kaliszewski, Maksymilian Ludwig, Maria Greniuk, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 2028-2028
Open Access | Times Cited: 10
Narrative Review of Immunotherapy in Gastroentero-Pancreatic Neuroendocrine Neoplasms
Jasmeet Kaur, Namrata Vijayvergia
Current Oncology (2023) Vol. 30, Iss. 9, pp. 8653-8664
Open Access | Times Cited: 5
Jasmeet Kaur, Namrata Vijayvergia
Current Oncology (2023) Vol. 30, Iss. 9, pp. 8653-8664
Open Access | Times Cited: 5
Spectrum of therapy-related clonal cytopenias and neoplasms after exposure to Lutetium-177-Dotatate
Stephanie L. Pritzl, Yael Kusne, Þorvarður R. Hálfdánarson, et al.
Leukemia Research (2023) Vol. 136, pp. 107434-107434
Closed Access | Times Cited: 4
Stephanie L. Pritzl, Yael Kusne, Þorvarður R. Hálfdánarson, et al.
Leukemia Research (2023) Vol. 136, pp. 107434-107434
Closed Access | Times Cited: 4
Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience
Vladimir Vukomanović, Katarina Vuleta Nedic, Marija Živković Radojević, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 1
Vladimir Vukomanović, Katarina Vuleta Nedic, Marija Živković Radojević, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 1
Developing a peripheral blood RNA ‐seq based NETseq ensemble classifier: A potential novel tool for non‐invasive detection and treatment response assessment in neuroendocrine tumor patients receiving 177Lu ‐DOTATATE PRRT
Mahesh Kumar Padwal, Rahul V. Parghane, Avik Chakraborty, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 1
Mahesh Kumar Padwal, Rahul V. Parghane, Avik Chakraborty, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 1
Assessment of VEGF and VEGF R1 serum levels in patients with neuroendocrine neoplasms before and after treatment with first-generation somatostatin analogues
Violetta Rosiek, Ksenia Janas
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 612-618
Open Access | Times Cited: 4
Violetta Rosiek, Ksenia Janas
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 612-618
Open Access | Times Cited: 4
Current and Emerging Therapies for Neuroendocrine Prostate Cancer
Tanya Stoyanova, Busola R. Alabi, Shiqin Liu
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 3
Tanya Stoyanova, Busola R. Alabi, Shiqin Liu
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 3
Incidental Finding of a Periampullary Neuroendocrine Tumor: A Case Report
Anjala Nizam, Nadia M Saleem, Tiba A Albakri, et al.
Cureus (2023)
Open Access | Times Cited: 1
Anjala Nizam, Nadia M Saleem, Tiba A Albakri, et al.
Cureus (2023)
Open Access | Times Cited: 1
Ectopic Hormonal Syndromes: Cushing's Syndrome and Acromegaly
Claudia Ramírez‐Rentería
Archives of Medical Research (2023) Vol. 54, Iss. 8, pp. 102898-102898
Open Access | Times Cited: 1
Claudia Ramírez‐Rentería
Archives of Medical Research (2023) Vol. 54, Iss. 8, pp. 102898-102898
Open Access | Times Cited: 1
Virtual Care for Patients with Advanced Well Differentiated Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
William J. Phillips, Michelle Pradier, Rachel Goodwin, et al.
Current Oncology (2024) Vol. 31, Iss. 2, pp. 952-961
Open Access
William J. Phillips, Michelle Pradier, Rachel Goodwin, et al.
Current Oncology (2024) Vol. 31, Iss. 2, pp. 952-961
Open Access
Childhood pancreatic neuroendocrine neoplasms: A national experience
T. Courtel, Daniel Orbach, Brigitte Lacour, et al.
Pediatric Blood & Cancer (2024)
Closed Access
T. Courtel, Daniel Orbach, Brigitte Lacour, et al.
Pediatric Blood & Cancer (2024)
Closed Access
Surgical and oncologic outcomes for liver resections of cystic neuroendocrine tumor liver metastasis
Markus Ammann, S.K. Adjei Antwi, Hallbera Gudmundsdottir, et al.
European Journal of Surgical Oncology (2024), pp. 109464-109464
Closed Access
Markus Ammann, S.K. Adjei Antwi, Hallbera Gudmundsdottir, et al.
European Journal of Surgical Oncology (2024), pp. 109464-109464
Closed Access
Sequencing of Therapies in Progressive Neuroendocrine Tumors
James R. Howe
Annals of Surgical Oncology (2022) Vol. 29, Iss. 11, pp. 6501-6503
Open Access | Times Cited: 2
James R. Howe
Annals of Surgical Oncology (2022) Vol. 29, Iss. 11, pp. 6501-6503
Open Access | Times Cited: 2
A 46-Year-Old Woman With Chronic Dyspnea and Diarrhea
Sabin Kshattry, MARY LOUISE WHITE, Jeremy Tchack, et al.
CHEST Journal (2023) Vol. 163, Iss. 1, pp. e23-e29
Open Access
Sabin Kshattry, MARY LOUISE WHITE, Jeremy Tchack, et al.
CHEST Journal (2023) Vol. 163, Iss. 1, pp. e23-e29
Open Access
